Spotlight: Flu Vaccines and Neurological Problems

Neurological problems due to nerve damage after vaccination is a fairly common adverse event with flu vaccines. In 1976, there were more cases of Guillain-Barre Syndrome reported after vaccination than there were confirmed cases of Swine flu.

FOR IMMEDIATE RELEASE

PRLog (Press Release) Feb 07, 2011 – Every vaccine on the market is associated with certain risks. Flu vaccines are no exception. As government agencies and medical authorities around the world urge entire populations to protect themselves from the latest strains of flu, little is said about the potential risks associated with this year’s miracle cures.

The 1976 swine flu vaccination campaign was abruptly halted when 500 cases of Guillain-Barré Syndrome (GBS) were diagnosed after vaccination. GBS is a rare, life threatening disease in which the body’s immune system attacks peripheral nerves (those outside the brain and spinal cord) destroying the myelin sheath surrounding them. This destruction leads to a multitude of possible symptoms, usually beginning with weakness or tingling in the legs. The unusual sensations increase in intensity until the muscles can no longer be used. Symptoms progress rapidly toward the upper body, sometimes resulting in total paralysis and death.

Guillain-Barré Syndrome is associated with several flu vaccines, the most common being swine flu vaccine. There is no cure for GBS, but therapy can sometimes lessen the severity and restore some of the original muscle function.

Guillain-Barré Syndrome is considered to be a severe enough threat that prior to the 2009 flu season, the Health Protection Agency in the United Kingdom sent a warning letter to 600 neurologists throughout the country telling them to watch for GBS symptoms because it could be triggered by the swine flu vaccine. This letter sparked a huge protest when leaked to the public because the Health Protection Agency did nothing to warn the millions of potential recipients of the vaccine prior to their National Flu Vaccination Campaign. (See verification here: http://www.dailymail.co.uk/news/article-1206807/Swine-fl …)

Nerve damage resulting from flu vaccines can also present itself as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). CIDP is closely related to GBS in the fact that it is also a result of nerve damage caused by destruction of the myelin sheaths surrounding peripheral nerves. CIDP also begins with unusual sensations in the arms and legs, progressive weakness and loss of muscle use. The only real difference between GBS and CIDP is the latter does not come on so suddenly and is a long-lasting or chronic condition.

On 1 February 2011, The Washington Post published, “Finland: link between swine flu shot, narcolepsy.”

Narcolepsy is a rare neurological disorder that causes the brain to be unable to regulate a person’s sleep cycles. A person with nerve damage causing this disorder could be talking to you and suddenly just fall asleep for a few seconds, minutes, or hours. Of the 60 young people in Finland who were diagnosed with this disorder during the 2009 flu season, almost 90% had recently received a vaccine to combat the flu. (for more information see: http://www.washingtonpost.com/wp-dyn/content/article/201 …)

It seems medical consumers are left with a serious question. Is it better to take your chances with the flu, or take your chances with a flu vaccine?

# # #

SaneVax believes only Safe, Affordable, Necessary & Effective vaccines and vaccination practices should be offered to the public. Our primary goal is to provide scientific information/resources for those concerned about vaccine safety, efficacy and need.
PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.